Three-time Super Bowl champion Julian Edelman remains unbothered by the pursuit of Hall of Fame glory. Interestingly, Edelman ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

The Edmonton Oilers overcame two deficits in Minnesota Wednesday to register a 5-3 win, behind the timely goaltending of Calvin Pickard. The Wild shot out to a deserved 2-0 lead as the Oilers got ...

NASCAR Hall of Famer Jimmie Johnson will attempt to qualify for the 2025 Daytona 500 (Feb. 16, 2:30 p.m. ET, FOX, MRN Radio, SiriusXM NASCAR Radio), the seven-time NASCAR Cup Series champion annou ...

The Ravens' surprising waiver claim for journeyman Diontae Johnson could result in an additional draft pick for Baltimore. Johnson, who was waived by Baltimore earlier this season, was claimed by ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Randy Moss and Calvin Johnson. James also mentioned legendary Chiefs and Atlanta Falcons tight end Tony Gonzalez, noting that he was a basketball star in high school and college before becoming ...

Diontae Johnson has been claimed on waivers by the Baltimore Ravens one day after he parted ways with the Houston Texans, according to ESPN's Adam Schefter. Johnson joined the Texans on Dec. 26 ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Magic Johnson is on another playoff run. Now Johnson is experiencing the NFL postseason for the first time as a minority owner of the Washington Commanders, a team that has a storied NFL history ...

The purchase will allow Johnson & Johnson to delve further into the treatment of central nervous system disorders. The purchase is one of several transactions in recent years to boost its ...

Johnson & Johnson (NYSE:JNJ) announced a $14.6 billion acquisition of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ahead of this week’s JP Morgan Healthcare Conference. Shares of Intra-Cellular ...